>…I do not see the difference in our views on this one.<
We agree completely on the economic motivations but we may differ on the probabilities.
Based on your posts, I would guess that you think the probability of Sanofi’s launching an AG into a market with only one approved generic is less than 20%. I think the probability is about 35%.
Market Data 
Markets 
AI
